Skip to main content
. 2019 Jul 29;68(12):2195–2205. doi: 10.1136/gutjnl-2019-318882

Figure 5.

Figure 5

Further evaluation of the 5hmC-based diagnostic model. (A) The performance of the wd-scores or AFP in distinguishing HCC from controls is shown for the independent validation set 2. (B) For those patients with confirmed stages, the performance of the wd-scores or AFP in distinguishing early or late HCC from controls is shown for validation set 2. (C) The boxplots show the relationships between wd-scores and the clinical diagnosis across the training set and both validation sets. Control: healthy individuals and  patients  with benign liver lesions. AFP, α-fetoprotein; AUC, area under curve; CHB, chronic hepatitis B virus infection; HCC, hepatocellular carcinoma; 5hmC, 5-hydroxymethylcytosines; LC, liver cirrhosis; wd-score, weighted diagnostic score.